366 results on '"Gressner, Axel"'
Search Results
2. Increased serum xylosyltransferase activity in patients with liver fibrosis
3. Impact of quality control accepted inter-laboratory variations on calculated Fibrotest/Actitest scores for the non-invasive biochemical assessment of liver fibrosis
4. Evaluation of serum percent trisialotransferrin as potential predictive biomarker of hepatocellular dedifferentiation in chronic liver disease
5. Questioning the role of actinfree Gc-Globulin as actin scavenger in neurodegenerative central nervous system disease: Relationship to S-100B levels and blood–brain barrier function
6. Platelet-derived growth factor isoform expression in carbon tetrachloride-induced chronic liver injury
7. Transforming growth factor β1 gene variants increase transcription and are associated with liver cirrhosis in Chinese
8. Evaluation of a novel reverse-hybridization StripAssay for typing DNA variants useful in diagnosis of adult-type hypolactasia
9. Gc-globulin (vitamin D binding protein) is synthesized and secreted by hepatocytes and internalized by hepatic stellate cells through Ca 2+-dependent interaction with the megalin/gp330 receptor
10. Pitfalls in LightCycler diagnosis of the single-nucleotide polymorphism 13.9 kb upstream of the lactase gene that is associated with adult-type hypolactasia
11. IFN-γ abrogates profibrogenic TGF-β signaling in liver by targeting expression of inhibitory and receptor Smads
12. Saliva collection method affects predictability of serum cortisol
13. Biomarkers of liver fibrosis: Clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests
14. High prevalence of increased trisialotransferrin concentrations in patients with anorexia nervosa: Implications for determination of carbohydrate-deficient transferrin
15. Heterophile Antikörper, fehlende Kommunikation und das diagnostische Dilemma
16. Cryopreservation of hepatic stellate cells
17. Elevation of Nε-(carboxymethyl)lysine-modified advanced glycation end products in chronic liver disease is an indicator of liver cirrhosis
18. Argininosuccinate lyase deficiency (ASL) and carbohydrate-deficient transferrin (CDT): Experience with four independent CDT analysis methods — misleading results given by the %CDT TIA assay
19. Primary biliary cirrhosis is not a clinical condition for increased carbohydrate-deficient transferrin: Experience with four independent CDT analysis methods
20. Genomic locus and promoter region of rat Smad7, an important antagonist of TGFβ signaling
21. Molecular and functional aspects of latent transforming growth factor-β binding protein: just a masking protein?
22. The cell biology of liver fibrogenesis – an imbalance of proliferation, growth arrest and apoptosis of myofibroblasts
23. Identification of paraxanthine as the most potent caffeine-derived inhibitor of connective tissue growth factor expression in liver parenchymal cells
24. Elevated concentrations of 15-deoxy-Δ12,14-prostaglandin J2 in chronic liver disease propose therapeutic trials with peroxisome proliferator activated receptor γ-inducing drugs
25. Altered factor VII activating protease expression in murine hepatic fibrosis and its influence on hepatic stellate cells
26. Expression patterns of PDGF-A, -B, -C and -D and the PDGF-receptors α and β in activated rat hepatic stellate cells (HSC)
27. Patients with acute on chronic liver failure display ‘sepsis-like’ immune paralysis
28. Activation of TGF-β within cultured hepatocytes and in liver injury leads to intracrine signaling with expression of connective tissue growth factor
29. Intracrine signalling of activin A in hepatocytes upregulates connective tissue growth factor (CTGF/CCN2) expression
30. Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases
31. Changing the pathogenetic roadmap of liver fibrosis? Where did it start; where will it go?
32. Maternal factor V Leiden mutation is associated with HELLP syndrome in Caucasian women
33. Alternative antibody for the detection of CA19-9 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access® GI Monitor assay on the UniCel® DxI 800 Immunoassay System
34. Alternative antibody for the detection of CA15-3 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access® BR Monitor assay on the UniCel® DxI 800 Immunoassay System
35. Alternative antibody for the detection of CA125 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access® OV Monitor assay on the UniCel® DxI 800 Immunoassay System
36. Evaluation of hepatotropic targeting properties of allogenic and xenogenic erythrocyte ghosts in normal and liver-injured rats
37. Decreased Plasminogen Activator Inhibitor and Tissue Metalloproteinase Inhibitor Expression May Promote Increased Metalloproteinase Activity with Increasing Duration of Human Atrial Fibrillation
38. Immortal hepatic stellate cell lines: useful tools to study hepatic stellate cell biology and function?
39. Insulin Resistance in Liver Cirrhosis Is Not Associated With Circulating Retinol-Binding Protein 4
40. Ito Cells Are Liver-Resident Antigen-Presenting Cells for Activating T Cell Responses
41. Relation of haemofilter type to venous catheter resistance is crucial for filtration performance and haemocompatibility in CVVH—an in vitro study
42. Resistin Serum Levels Are Associated with Insulin Resistance, Disease Severity, Clinical Complications, and Prognosis in Patients with Chronic Liver Diseases
43. Technical evaluation of the Beckman Coulter OV-Monitor (CA 125 antigen) immunoassay
44. Global analysis of host tissue gene expression in the invasive front of colorectal liver metastases
45. Tumor necrosis factor alpha (TNFα) and transforming growth factor β1 (TGFβ1) stimulate fibronectin synthesis and the transdifferentiation of fat-storing cells in the rat liver into myofibroblasts
46. N-Acetyl-l-cysteine suppresses TGF-β signaling at distinct molecular steps: The biochemical and biological efficacy of a multifunctional, antifibrotic drug
47. Albumin and hydroxyethyl starch 130 kDa/0.4 improve filter clearance and haemocompatibility in haemo- and plasmafiltration—an in vitro study
48. Corticosteroids stimulate selectively transforming growth factor (TGF)-β receptor type III expression in transdifferentiating hepatic stellate cells
49. Prevalence of Pituitary Deficiency in Patients after Aneurysmal Subarachnoid Hemorrhage
50. Common heterozygous hemochromatosis gene mutations are risk factors for inflammation and fibrosis in chronic hepatitis C
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.